Cargando…
Early reduction of left atrial function predicts adverse clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement
AIMS: To investigate the changes in left atrial strain (LAS) after correction of severe aortic stenosis (AS) with transcatheter aortic valve replacement (TAVR) and assess its prognostic impact. METHODS AND RESULTS: One hundred consecutive patients with severe symptomatic AS who underwent TAVR at the...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264907/ https://www.ncbi.nlm.nih.gov/pubmed/34233914 http://dx.doi.org/10.1136/openhrt-2021-001685 |
_version_ | 1783719661901185024 |
---|---|
author | Sabatino, Jolanda De Rosa, Salvatore Leo, Isabella Strangio, Antonio La Bella, Sabrina Sorrentino, Sabato Mongiardo, Annalisa Spaccarotella, Carmen Polimeni, Alberto Indolfi, Ciro |
author_facet | Sabatino, Jolanda De Rosa, Salvatore Leo, Isabella Strangio, Antonio La Bella, Sabrina Sorrentino, Sabato Mongiardo, Annalisa Spaccarotella, Carmen Polimeni, Alberto Indolfi, Ciro |
author_sort | Sabatino, Jolanda |
collection | PubMed |
description | AIMS: To investigate the changes in left atrial strain (LAS) after correction of severe aortic stenosis (AS) with transcatheter aortic valve replacement (TAVR) and assess its prognostic impact. METHODS AND RESULTS: One hundred consecutive patients with severe symptomatic AS who underwent TAVR at the Magna Graecia University of Catanzaro underwent echocardiographic examination including assessment of LAS before and after TAVR. Independent investigators collected outcome data and information. The primary study outcome was the difference in ΔLAS (postTAVR–preTAVR) between patients those met the main clinical endpoint (a composite of cardiovascular mortality and heart failure hospitalisation) and those not meeting the endpoint. During a median follow-up of 31 months, 35 patients (35%) met the combined clinical endpoint. The difference between LAS post-TAVR and LAS pre-TAVR (ΔLAS) was significantly larger in patients who met the combined endpoint (HR=0.76 (0.67–0.86); p<0.001). Multivariate logistic regression analysis including ΔLAS, EuroSCORE II and left ventricular ejection fraction showed that ΔLAS (HR=0.80, p<0.001) was the only independent predictor of the combined clinical endpoint. Finally, a Kaplan-Maier analysis showed that patients with a ΔLAS above its median value had a significantly better event-free survival compared with those below the median (p<0.001). CONCLUSIONS: A lower reduction in ΔLAS after TAVR was an independent predictor of the primary composite outcome of cardiovascular death and hospitalisation for heart failure. |
format | Online Article Text |
id | pubmed-8264907 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-82649072021-07-23 Early reduction of left atrial function predicts adverse clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement Sabatino, Jolanda De Rosa, Salvatore Leo, Isabella Strangio, Antonio La Bella, Sabrina Sorrentino, Sabato Mongiardo, Annalisa Spaccarotella, Carmen Polimeni, Alberto Indolfi, Ciro Open Heart Valvular Heart Disease AIMS: To investigate the changes in left atrial strain (LAS) after correction of severe aortic stenosis (AS) with transcatheter aortic valve replacement (TAVR) and assess its prognostic impact. METHODS AND RESULTS: One hundred consecutive patients with severe symptomatic AS who underwent TAVR at the Magna Graecia University of Catanzaro underwent echocardiographic examination including assessment of LAS before and after TAVR. Independent investigators collected outcome data and information. The primary study outcome was the difference in ΔLAS (postTAVR–preTAVR) between patients those met the main clinical endpoint (a composite of cardiovascular mortality and heart failure hospitalisation) and those not meeting the endpoint. During a median follow-up of 31 months, 35 patients (35%) met the combined clinical endpoint. The difference between LAS post-TAVR and LAS pre-TAVR (ΔLAS) was significantly larger in patients who met the combined endpoint (HR=0.76 (0.67–0.86); p<0.001). Multivariate logistic regression analysis including ΔLAS, EuroSCORE II and left ventricular ejection fraction showed that ΔLAS (HR=0.80, p<0.001) was the only independent predictor of the combined clinical endpoint. Finally, a Kaplan-Maier analysis showed that patients with a ΔLAS above its median value had a significantly better event-free survival compared with those below the median (p<0.001). CONCLUSIONS: A lower reduction in ΔLAS after TAVR was an independent predictor of the primary composite outcome of cardiovascular death and hospitalisation for heart failure. BMJ Publishing Group 2021-07-07 /pmc/articles/PMC8264907/ /pubmed/34233914 http://dx.doi.org/10.1136/openhrt-2021-001685 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Valvular Heart Disease Sabatino, Jolanda De Rosa, Salvatore Leo, Isabella Strangio, Antonio La Bella, Sabrina Sorrentino, Sabato Mongiardo, Annalisa Spaccarotella, Carmen Polimeni, Alberto Indolfi, Ciro Early reduction of left atrial function predicts adverse clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement |
title | Early reduction of left atrial function predicts adverse clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement |
title_full | Early reduction of left atrial function predicts adverse clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement |
title_fullStr | Early reduction of left atrial function predicts adverse clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement |
title_full_unstemmed | Early reduction of left atrial function predicts adverse clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement |
title_short | Early reduction of left atrial function predicts adverse clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement |
title_sort | early reduction of left atrial function predicts adverse clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement |
topic | Valvular Heart Disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264907/ https://www.ncbi.nlm.nih.gov/pubmed/34233914 http://dx.doi.org/10.1136/openhrt-2021-001685 |
work_keys_str_mv | AT sabatinojolanda earlyreductionofleftatrialfunctionpredictsadverseclinicaloutcomesinpatientswithsevereaorticstenosisundergoingtranscatheteraorticvalvereplacement AT derosasalvatore earlyreductionofleftatrialfunctionpredictsadverseclinicaloutcomesinpatientswithsevereaorticstenosisundergoingtranscatheteraorticvalvereplacement AT leoisabella earlyreductionofleftatrialfunctionpredictsadverseclinicaloutcomesinpatientswithsevereaorticstenosisundergoingtranscatheteraorticvalvereplacement AT strangioantonio earlyreductionofleftatrialfunctionpredictsadverseclinicaloutcomesinpatientswithsevereaorticstenosisundergoingtranscatheteraorticvalvereplacement AT labellasabrina earlyreductionofleftatrialfunctionpredictsadverseclinicaloutcomesinpatientswithsevereaorticstenosisundergoingtranscatheteraorticvalvereplacement AT sorrentinosabato earlyreductionofleftatrialfunctionpredictsadverseclinicaloutcomesinpatientswithsevereaorticstenosisundergoingtranscatheteraorticvalvereplacement AT mongiardoannalisa earlyreductionofleftatrialfunctionpredictsadverseclinicaloutcomesinpatientswithsevereaorticstenosisundergoingtranscatheteraorticvalvereplacement AT spaccarotellacarmen earlyreductionofleftatrialfunctionpredictsadverseclinicaloutcomesinpatientswithsevereaorticstenosisundergoingtranscatheteraorticvalvereplacement AT polimenialberto earlyreductionofleftatrialfunctionpredictsadverseclinicaloutcomesinpatientswithsevereaorticstenosisundergoingtranscatheteraorticvalvereplacement AT indolficiro earlyreductionofleftatrialfunctionpredictsadverseclinicaloutcomesinpatientswithsevereaorticstenosisundergoingtranscatheteraorticvalvereplacement |